Skip to main content

Find Clinical Trials

Home
Conditions
Atypical Lobular Hyperplasia (ALH) of Breast

Clinical trial condition

Atypical Lobular Hyperplasia (ALH) of Breast

Explore clinical trials studying Atypical Lobular Hyperplasia (ALH) of Breast. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Atypical Lobular Hyperplasia (ALH) of Breast trial results

Completed

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

NCT01372644

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Atypical Lobular Hyperplasia (ALH) of Breast, +14 more
Locations: NYU School of Medicine New York, United States

View Trial Details